Literature DB >> 29934657

A case of multiple familial trichoepitheliomas responding to treatment with the Hedgehog signaling pathway inhibitor vismodegib.

Vera Baur1, Thomas Papadopoulos2, Dmitry V Kazakov3, Abbas Agaimy4, Arndt Hartmann4, Georg Isbary5, Ralph M Wirtz6, Erwin S Schultz7.   

Abstract

Multiple familial trichoepitheliomas (MFT) is an autosomal dominantly inherited disease characterized by multiple skin appendage tumors. We describe a patient showing a continuous spectrum of follicular differentiated neoplasms including classical trichoepitheliomas but also infiltrative growing and finally metastasizing malignant follicular differentiated tumors. Germline mutation analysis revealed a nonsense mutation in the cylindromatosis (CYLD) gene. Gene expression analysis by real-time PCR of tumor tissue showed overexpression of glioma-associated oncogene Gli1 mRNA. Treatment with the Hedgehog pathway inhibitor vismodegib resulted in a significant regression of the highly differentiated trichoepitheliomas. Gli upregulation is indicative of an active Hedgehog signaling pathway. We hypothesize that its upregulation is indirectly caused by CYLD mutation which promotes tumor development. Vismodegib treatment could thus provide a new treatment option for patients with this debilitating disorder.

Entities:  

Keywords:  Brooke syndrome; CYLD; Hedgehog pathway; Trichoepithelioma; Vismodegib

Mesh:

Substances:

Year:  2018        PMID: 29934657     DOI: 10.1007/s00428-018-2397-y

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  14 in total

1.  Brooke-Spiegler syndrome: report of 10 patients from 8 families with novel germline mutations: evidence of diverse somatic mutations in the same patient regardless of tumor type.

Authors:  Radek Sima; Tomas Vanecek; Denisa Kacerovska; Pavel Trubac; Bernard Cribier; Arno Rutten; Marina Vazmitel; Dominic V Spagnolo; Radek Litvik; Yvetta Vantuchova; Wolfgang Weyers; Robert L Pearce; John Pearn; Michal Michal; Dmitry V Kazakov
Journal:  Diagn Mol Pathol       Date:  2010-06

Review 2.  CYLD: a tumor suppressor deubiquitinase regulating NF-kappaB activation and diverse biological processes.

Authors:  S-C Sun
Journal:  Cell Death Differ       Date:  2010-01       Impact factor: 15.828

3.  Vismodegib induces significant clinical response in locally advanced trichoblastic carcinoma.

Authors:  P Lepesant; M Crinquette; S Alkeraye; X Mirabel; V Dziwniel; B Cribier; L Mortier
Journal:  Br J Dermatol       Date:  2015-08-27       Impact factor: 9.302

4.  Mutations in the CYLD gene in Brooke-Spiegler syndrome, familial cylindromatosis, and multiple familial trichoepithelioma: lack of genotype-phenotype correlation.

Authors:  Sarah Bowen; Melissa Gill; David A Lee; Galen Fisher; Roy G Geronemus; Marialuisa Espinel Vazquez; Julide Tok Celebi
Journal:  J Invest Dermatol       Date:  2005-05       Impact factor: 8.551

5.  Brooke-Spiegler syndrome: report of a case with a novel mutation in the CYLD gene and different types of somatic mutations in benign and malignant tumors.

Authors:  Dmitry V Kazakov; Jörg Schaller; Tomas Vanecek; Denisa Kacerovska; Michal Michal
Journal:  J Cutan Pathol       Date:  2010-02-04       Impact factor: 1.587

Review 6.  Basal cell carcinomas: attack of the hedgehog.

Authors:  Ervin H Epstein
Journal:  Nat Rev Cancer       Date:  2008-10       Impact factor: 60.716

7.  RNA extraction from archival formalin-fixed paraffin-embedded tissue: a comparison of manual, semiautomated, and fully automated purification methods.

Authors:  Kerstin Bohmann; Guido Hennig; Uwe Rogel; Christopher Poremba; Berit Maria Mueller; Peter Fritz; Stephan Stoerkel; Karl-L Schaefer
Journal:  Clin Chem       Date:  2009-07-17       Impact factor: 8.327

Review 8.  Malignant transformation of multiple familial trichoepithelioma: case report and literature review.

Authors:  Kyung Ho Lee; Jung Eun Kim; Baik Kee Cho; Yu Chan Kim; Chul Jong Park
Journal:  Acta Derm Venereol       Date:  2008       Impact factor: 4.437

9.  Malignant hair matrix tumor ("malignant trichoepithelioma") arising in the setting of multiple hereditary trichoepithelioma.

Authors:  S J Hunt; E Abell
Journal:  Am J Dermatopathol       Date:  1991-06       Impact factor: 1.533

10.  Tumor Suppressor Function of CYLD in Nonmelanoma Skin Cancer.

Authors:  K C Masoumi; Gina Shaw-Hallgren; Ramin Massoumi
Journal:  J Skin Cancer       Date:  2011-12-17
View more
  1 in total

Review 1.  CYLD Alterations in the Tumorigenesis and Progression of Human Papillomavirus-Associated Head and Neck Cancers.

Authors:  Zhibin Cui; Hyunseok Kang; Jennifer R Grandis; Daniel E Johnson
Journal:  Mol Cancer Res       Date:  2020-09-03       Impact factor: 6.333

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.